Home » Stryker Boosts GMP Compliance Spending, Again
Stryker Boosts GMP Compliance Spending, Again
Stryker plans to increase good manufacturing practice (GMP) compliance-related spending by as much as $40 million this year as it continues its efforts to remediate quality system issues. Multiple FDA warning letters and a temporary production stoppage last year for its hip replacement implants forced Stryker to implement a global, corporatewide GMP compliance program, which cost an additional $50 million to $55 million in 2008.
The GMP Letter
The GMP Letter
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May